Efficacy and tolerance of liposomal daunorubicin in Kaposi sarcoma associated with human immunodeficiency virus infection

Saved in:

Bibliographic Details
Published in:	Archives of dermatology (1960) Vol. 133; no. 7; p. 918
Main Authors:	Fournier, S, Dupont, B, Pialoux, G, Eliaszewicz, M, Gonzalez-Canali, G, Feuillie, V
Format:	Journal Article
Language:	English
Published:	United States 01-07-1997
Subjects:	AIDS-Related Opportunistic Infections - drug therapy Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - adverse effects CD4 Lymphocyte Count Daunorubicin - administration & dosage Daunorubicin - adverse effects Digestive System Neoplasms - drug therapy Disease Progression Drug Carriers Humans Liposomes Lung Neoplasms - drug therapy Remission Induction Sarcoma, Kaposi - drug therapy Skin Neoplasms - drug therapy Survival Rate
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0003-987X
DOI:	10.1001/archderm.1997.03890430140026